Ethmoiditis-associated apex syndrome may result in temporary blindness after allo-SCT

被引：0
|
作者：
Olsson, R. [1 ]
Juto, J-E [2 ]
Mattsson, J. [1 ]
机构：
[1] Karolinska Univ Hosp, Karolinska Inst, Ctr Allogene Stem Cell Transplantat, Huddinge, Sweden
[2] Karolinska Univ Hosp, Karolinska Inst, Dept Otorhinolaryngol, Huddinge, Sweden
来源：
BONE MARROW TRANSPLANTATION | 2009年 / 44卷 / 12期
关键词：
STEM-CELL TRANSPLANTATION; FUNGAL-INFECTIONS; RECIPIENTS; SINUSITIS;
D O I：
10.1038/bmt.2009.85
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：825 / 826
页数：2
相关论文
共 42 条
  • [1] Ethmoiditis-associated apex syndrome may result in temporary blindness after allo-SCT
    R Olsson
    J-E Juto
    J Mattsson
    Bone Marrow Transplantation, 2009, 44 : 825 - 826
  • [2] CLINICAL FACTORS ASSOCIATED WITH IMMUNOGLOBULINS AFTER ALLO-SCT
    Blanco Sanchez, Alberto
    Sanchez Pina, Jose Maria
    Saez Marin, Adolfo
    Ramos Moreno, Guillermo
    Parra Virto, Esther
    Tamayo Soto, Andrea
    Alba Medina, Lucia
    Mas Babio, Reyes
    Calbacho Robles, Maria
    Martinez-Lopez, Joaquin
    BONE MARROW TRANSPLANTATION, 2024, 59 : 512 - 512
  • [3] Lung transplantation for bronchiolitis obliterans syndrome after allo-SCT
    Holm, A. M.
    Riise, G. C.
    Hansson, L.
    Brinch, L.
    Bjortuft, O.
    Iversen, M.
    Simonsen, S.
    Floisand, Y.
    BONE MARROW TRANSPLANTATION, 2013, 48 (05) : 703 - 707
  • [4] Lung transplantation for bronchiolitis obliterans syndrome after allo-SCT
    A M Holm
    G C Riise
    L Hansson
    L Brinch
    Ø Bjørtuft
    M Iversen
    S Simonsen
    Y Fløisand
    Bone Marrow Transplantation, 2013, 48 : 703 - 707
  • [5] Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome
    L De Padua Silva
    M de Lima
    H Kantarjian
    S Faderl
    P Kebriaei
    S Giralt
    J Davisson
    G Garcia-Manero
    R Champlin
    J-P Issa
    F Ravandi
    Bone Marrow Transplantation, 2009, 43 : 839 - 843
  • [6] Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome
    Silva, L. De Padua
    de Lima, M.
    Kantarjian, H.
    Faderl, S.
    Kebriaei, P.
    Giralt, S.
    Davisson, J.
    Garcia-Manero, G.
    Champlin, R.
    Issa, J-P
    Ravandi, F.
    BONE MARROW TRANSPLANTATION, 2009, 43 (11) : 839 - 843
  • [7] Early detection of relapse in patients with myelodysplastic syndrome after allo-SCT
    M Tobiasson
    R Olsson
    E Hellström-Lindberg
    J Mattsson
    Bone Marrow Transplantation, 2011, 46 : 719 - 726
  • [8] Early detection of relapse in patients with myelodysplastic syndrome after allo-SCT
    Tobiasson, M.
    Olsson, R.
    Hellstrom-Lindberg, E.
    Mattsson, J.
    BONE MARROW TRANSPLANTATION, 2011, 46 (05) : 719 - 726
  • [9] CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML
    Ito, S.
    Pophali, P.
    Wu, C. O.
    Koklanaris, E. K.
    Superata, J.
    Fahle, G. A.
    Childs, R.
    Battiwalla, M.
    Barrett, A. J.
    BONE MARROW TRANSPLANTATION, 2013, 48 (10) : 1313 - 1316
  • [10] CMV Reactivation Is Associated With a Lower Incidence Of Relapse After Allo-SCT For ALL
    Tian, Hong
    Xu, Yang
    Yang, Zhen
    Chen, Guanghua
    Qiao, Man
    Liu, Huiwen
    Wu Depei
    BLOOD, 2013, 122 (21)
12345